Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,841 | -3,876 | -12,301 | -665 | 13,693 |
| Depreciation Amortization | 51 | 23 | 2,343 | 1,766 | 1,173 |
| Accounts receivable | N/A | N/A | 7,971 | 8,129 | -7,828 |
| Accounts payable and accrued liabilities | -421 | 62 | -4,140 | -4,545 | -3,514 |
| Other Working Capital | -185 | -170 | -48,554 | -43,889 | -52,797 |
| Other Operating Activity | 501 | -36 | 8,723 | 6,894 | 18,479 |
| Operating Cash Flow | $-7,895 | $-3,997 | $-45,958 | $-32,310 | $-30,794 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 27,330 | 26,666 | 12,946 |
| PPE Investments | -1,045 | -132 | -245 | -353 | -306 |
| Other Investing Activity | 0 | 0 | -6,000 | -6,000 | 0 |
| Investing Cash Flow | $-1,045 | $-132 | $21,085 | $20,313 | $12,640 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -3,827 | -3,587 | -2,166 |
| Common Stock Issued | 5 | 5 | 426 | 377 | 306 |
| Financing Cash Flow | $5 | $5 | $-3,401 | $-3,210 | $-1,860 |
| Beginning Cash Position | 15,862 | 15,862 | 60,335 | 60,335 | 60,335 |
| End Cash Position | 6,927 | 11,738 | 32,061 | 45,128 | 40,321 |
| Net Cash Flow | $-8,935 | $-4,124 | $-28,274 | $-15,207 | $-20,014 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,895 | -3,997 | -45,958 | -32,310 | -30,794 |
| Capital Expenditure | -1,045 | -132 | -381 | -353 | -306 |
| Free Cash Flow | -8,940 | -4,129 | -46,339 | -32,663 | -31,100 |